These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11116059)

  • 1. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice.
    Van Eck M; De Winther MP; Herijgers N; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2600-6. PubMed ID: 11116059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice.
    Herijgers N; de Winther MP; Van Eck M; Havekes LM; Hofker MH; Hoogerbrugge PM; Van Berkel TJ
    J Lipid Res; 2000 Sep; 41(9):1402-9. PubMed ID: 10974047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
    Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
    Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1.
    Arsiwala T; Pahla J; van Tits LJ; Bisceglie L; Gaul DS; Costantino S; Miranda MX; Nussbaum K; Stivala S; Blyszczuk P; Weber J; Tailleux A; Stein S; Paneni F; Beer JH; Greter M; Becher B; Mostoslavsky R; Eriksson U; Staels B; Auwerx J; Hottiger MO; Lüscher TF; Matter CM
    J Mol Cell Cardiol; 2020 Feb; 139():24-32. PubMed ID: 31972266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development.
    Van Eck M; Bos IS; Hildebrand RB; Van Rij BT; Van Berkel TJ
    Am J Pathol; 2004 Sep; 165(3):785-94. PubMed ID: 15331403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scavenger receptor classes A and B. Their roles in atherogenesis and the metabolism of modified LDL and HDL.
    Van Berkel TJ; Van Eck M; Herijgers N; Fluiter K; Nion S
    Ann N Y Acad Sci; 2000 May; 902():113-26; discussion 126-7. PubMed ID: 10865831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A.
    Babaev VR; Gleaves LA; Carter KJ; Suzuki H; Kodama T; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2593-9. PubMed ID: 11116058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertension.
    Sakamoto H; Aikawa M; Hill CC; Weiss D; Taylor WR; Libby P; Lee RT
    Circulation; 2001 Jul; 104(1):109-14. PubMed ID: 11435347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.
    Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW
    J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (op) and apolipoprotein E.
    de Villiers WJ; Smith JD; Miyata M; Dansky HM; Darley E; Gordon S
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):631-40. PubMed ID: 9555870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice.
    Van Berkel TJ; Van Velzen A; Kruijt JK; Suzuki H; Kodama T
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):29-35. PubMed ID: 9512458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage specific overexpression of the human macrophage scavenger receptor in transgenic mice, using a 180-kb yeast artificial chromosome, leads to enhanced foam cell formation of isolated peritoneal macrophages.
    de Winther MP; van Dijk KW; van Vlijmen BJ; Gijbels MJ; Heus JJ; Wijers ER; van den Bos AC; Breuer M; Frants RR; Havekes LM; Hofker MH
    Atherosclerosis; 1999 Dec; 147(2):339-47. PubMed ID: 10559520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.
    Ricci R; Sumara G; Sumara I; Rozenberg I; Kurrer M; Akhmedov A; Hersberger M; Eriksson U; Eberli FR; Becher B; Borén J; Chen M; Cybulsky MI; Moore KJ; Freeman MW; Wagner EF; Matter CM; Lüscher TF
    Science; 2004 Nov; 306(5701):1558-61. PubMed ID: 15567863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages.
    Whitman SC; Hazen SL; Miller DB; Hegele RA; Heinecke JW; Huff MW
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1238-49. PubMed ID: 10323775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis.
    De Winther MP; Gijbels MJ; Van Dijk KW; Havekes LM; Hofker MH
    Int J Tissue React; 2000; 22(2-3):85-91. PubMed ID: 10937358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-specific expression of class A scavenger receptors enhances granuloma formation in the absence of increased lipid deposition.
    Daugherty A; Kosswig N; Cornicelli JA; Whitman SC; Wolle S; Rateri DL
    J Lipid Res; 2001 Jul; 42(7):1049-55. PubMed ID: 11441131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells.
    Covey SD; Krieger M; Wang W; Penman M; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1589-94. PubMed ID: 12829524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.